News & Media

Access to New Medicines in Public Drug Plans

Some key findings from the report include:

  • From Health Canada approval to a medicine’s reimbursement by a provincial drug plan takes over a year – about 462 days on average, across public provincial plans comprising 80% of the national public plan population.
  • In 2014, only 23% of 141 Health Canada-approved new medicines were included in public plans, ranking Canada 17 out of 18, compared to other OECD countries.
  • In Canada, 29% of cancer medicines were covered in public drug plans across provinces comprising at least 80% of the eligible national public drug plan population, ranking Canada in 16th place of 18 countries.
  • Canadian public drug plans placed reimbursement conditions on 90% of new medicines when measured across provinces comprising 80% of the eligible national public drug plan population.
  • In Canada, 20% of new biologic medicines were reimbursed in public drug plans across provinces comprising at least 80% of the eligible national public drug plan population, putting Canada in 17th place of 18 countries.

Click  to view the news release and report.

Back

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe